0 Comment
Barcelona (EFE).- New drugs in the last phases of trials that can stop the progression of multiple sclerosis (MS) and a possible vaccine that hinders infection by the Epstein-Barr virus are the new “windows of opportunity” to change the paradigm of this neurodegenerative disease. This was explained this Monday by the director of the Multiple... Read More